Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1992;12:58-69

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nieminen, M. S.
Right arrow Articles by Taskinen, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nieminen, M. S.
Right arrow Articles by Taskinen, M. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*Genetics Home Reference

Arteriosclerosis and Thrombosis, Vol 12, 58-69, Copyright © 1992 by American Heart Association

ARTICLES

Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease

MS Nieminen, KJ Mattila, K Aalto-Setala, T Kuusi, K Kontula, R Kauppinen- Makelin, C Ehnholm, M Jauhiainen, M Valle and MR Taskinen
Department of Medicine, University of Helsinki, Finland.

To examine the concentration of serum lipoproteins and the association of their genetic variation with the occurrence of coronary artery disease (CAD), composite serum lipoprotein profiles including lipoprotein(a) (Lp[a]), apolipoprotein (apo) E phenotypes, and apo B Xba I genotypes were determined in patients with angiographically verified CAD (CAD+ group, n = 111) and in subjects with no angiographic evidence of CAD (CAD- group, n = 46). In addition, we determined the concentrations of serum lipids, lipoproteins, and apolipoproteins in 96 healthy controls. Both CAD- and CAD+ groups had lower concentrations of apos A-I and A-II but higher concentrations of serum total and very low density lipoprotein triglyceride and very low density lipoprotein cholesterol than did healthy controls. The mean concentrations of serum total and low density lipoprotein cholesterol and the median values of Lp(a) were similar in the CAD+ and CAD- groups, both having higher concentrations of low density lipoprotein cholesterol and apo B than the healthy controls. Irrespective of gender, patients with CAD had significantly lower serum high density lipoprotein cholesterol than did those without CAD (1.48 +/- 0.40 versus 1.16 +/- 0.29 mmol/l, p less than 0.001). In women, the mean serum total and very low density lipoprotein triglyceride concentration was also higher in the CAD+ than in the CAD- group. The frequency of the apo E4 allele (epsilon 4) was significantly higher in the CAD+ group (0.293) than in the CAD- group (0.174; p less than 0.001). The frequencies of the two apo B alleles, X1 (Xba I restriction site absent) and X2 (Xba I restriction site present), were similar in the two groups. Stepwise discriminant analysis revealed that in men, serum high density lipoprotein cholesterol had the highest power to discriminate for CAD. In addition, the concentration of plasma apo B levels and the occurrence of apo E phenotypes were independently associated with CAD in men. In women, the only independent factor associated with CAD after adjustment for beta- blocker and diuretics usage was the concentration of serum triglycerides.


This article has been cited by other articles:


Home page
 In VivoHome page
G. D. KOLOVOU, K. K. ANAGNOSTOPOULOU, P. KOSTAKOU, V. GIANNAKOPOULOU, C. MIHAS, G. HATZIGEORGIOU, I. K. VASILIADIS, D. P. MIKHAILIDIS, and D. V. COKKINOS
Apolipoprotein E Gene Polymorphism and Obesity Status in Middle-aged Men with Coronary Heart Disease
In Vivo, January 1, 2009; 23(1): 33 - 39.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. N. Ballesteros, R. M. Cabrera, M. del Socorro Saucedo, and M. L. Fernandez
Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 855 - 861.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Shimabukuro, M. Sunagawa, and T. Ohta
Low-Density Lipoprotein Particle Size and Its Regulatory Factors in School Children
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2923 - 2927.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M.C. Carr, A.F. Ayyobi, S.J. Murdoch, S.S. Deeb, and J.D. Brunzell
Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 667 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. F. Newman, D. T. Laskowitz, W. D. White, J. L. Kirchner, H. P. Grocott, M. Stafford-Smith, M. H. Sketch, R. H. Jones, J. G. Reves, and A. M. Saunders
Apolipoprotein E Polymorphisms and Age at First Coronary Artery Bypass Graft
Anesth. Analg., April 1, 2001; 92(4): 824 - 829.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. R. Isasi, S. Shea, R. J. Deckelbaum, S. C. Couch, T. J. Starc, J. D. Otvos, and L. Berglund
Apolipoprotein epsilon 2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study
Pediatrics, September 1, 2000; 106(3): 568 - 575.
[Abstract] [Full Text]

Home page
 Exp. Biol. Med.Home page
T. P. Carr, G. Cai, J.-Y. Lee, and C. L. Schneider
Cholesteryl Ester Enrichment of Plasma Low-Density Lipoproteins in Hamsters Fed Cereal-Based Diets Containing Cholesterol
Experimental Biology and Medicine, January 1, 2000; 223(1): 96 - 101.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. L. R. Kardia, M. B. Haviland, R. E. Ferrell, and C. F. Sing
The Relationship Between Risk Factor Levels and Presence of Coronary Artery Calcification is Dependent on Apolipoprotein E Genotype
Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 427 - 435.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H.E. Miettinen, H. Gylling, J. Tenhunen, J. Virtamo, M. Jauhiainen, J.K. Huttunen, I. Kantola, T.A. Miettinen, and K. Kontula
Molecular Genetic Study of Finns With Hypoalphalipoproteinemia and Hyperalphalipoproteinemia : A Novel Gly230Arg Mutation (LCATFin) of Lecithin:Cholesterol Acyltransferase (LCAT) Accounts for 5% of Cases With Very Low Serum HDL Cholesterol Levels
Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 591 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. E. Tardiff, M. F. Newman, A. M. Saunders, W. J. Strittmatter, J. A. Blumenthal, W. D. White, N. D. Croughwell, R. D. Davis Jr, A. D. Roses, and J. G. Reves
Preliminary Report of a Genetic Basis for Cognitive Decline After Cardiac Operations
Ann. Thorac. Surg., September 1, 1997; 64(3): 715 - 720.
[Abstract] [Full Text]

Home page
 StrokeHome page
J. G. Terry, G. Howard, M. Mercuri, M. G. Bond, and J. R. Crouse III
Apolipoprotein E Polymorphism Is Associated With Segment-Specific Extracranial Carotid Artery Intima-Media Thickening
Stroke, October 1, 1996; 27(10): 1755 - 1759.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H.G. Kraft, A. Lingenhel, S. Kochl, F. Hoppichler, F. Kronenberg, A. Abe, V. Muhlberger, D. Schonitzer, and G. Utermann
Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease
Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 713 - 719.
[Abstract] [Full Text]

Home page
 HypertensionHome page
Y. Nakata, T. Katsuya, H. Rakugi, S. Takami, M. Ohishi, K. Kamino, J. Higaki, Y. Tabuchi, Y. Kumahara, T. Miki, et al.
Polymorphism of the Apolipoprotein E and Angiotensin-Converting Enzyme Genes in Japanese Subjects With Silent Myocardial Ischemia
Hypertension, June 1, 1996; 27(6): 1205 - 1209.
[Abstract] [Full Text]

Home page
 Arch NeurolHome page
V. Hachinski, C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, A. Donner, J. D. Spence, G. Doig, and B. M. J. Wolfe
Lipids and Stroke: A Paradox Resolved
Arch Neurol, April 1, 1996; 53(4): 303 - 308.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Kuusisto, L. Mykkanen, K. Kervinen, Y. A. Kesaniemi, and M. Laakso
Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects
Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1280 - 1286.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. C. Klausen, U. Beisiegel, H.-J. Menzel, M. Rosseneu, V. Nicaud, and O. Faergeman
Apo(a) Phenotypes and Lp(a) Concentrations in Offspring of Men With and Without Myocardial Infarction : The EARS Study
Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1001 - 1008.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
X. L. Wang, R. M. McCredie, and D. E. L. Wilcken
Polymorphisms of the Apolipoprotein E Gene and Severity of Coronary Artery Disease Defined by Angiography
Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1030 - 1034.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Campos, G. O. Roederer, S. Lussier-Cacan, J. Davignon, and R. M. Krauss
Predominance of Large LDL and Reduced HDL2 Cholesterol in Normolipidemic Men With Coronary Artery Disease
Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1043 - 1048.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. Ferrieres, J. Lambert, S. Lussier-Cacan, and J. Davignon
Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation
Circulation, August 1, 1995; 92(3): 290 - 295.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. H. Stengard, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing
Apolipoprotein E Polymorphism Predicts Death From Coronary Heart Disease in a Longitudinal Study of Elderly Finnish Men
Circulation, January 15, 1995; 91(2): 265 - 269.
[Abstract] [Full Text]

Home page
 JAMAHome page
P. W. F. Wilson, R. H. Myers, M. G. Larson, J. M. Ordovas, P. A. Wolf, and E. J. Schaefer
Apolipoprotein E Alleles, Dyslipidemia, and Coronary Heart Disease: The Framingham Offspring Study
JAMA, December 7, 1994; 272(21): 1666 - 1671.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M.C. Carr, A.F. Ayyobi, S.J. Murdoch, S.S. Deeb, and J.D. Brunzell
Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 667 - 673.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.